EYE191220P00030000
| Previous Close | 0.7000 |
| Open | 0.7000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | N/A |
| Expire Date | 2019-12-20 |
| Day's Range | 0.7000 - 0.7000 |
| Contract Range | N/A |
| Volume | 2 |
| Open Interest | N/A |
- Zacks
NuVasive Hits New 52-Week High: What's Driving the Stock?
NuVasive (NUVA) is optimistic about maintaining the momentum on several positive developments.
- Zacks
TransMedics' OCS Technology Sees Success in Heart Transplant
TransMedics (TMDX) successfully completes heart transplants from DCD donors, using its OCS technology.
- GlobeNewswire
National Vision Welcomes Joan Blackwood as Chief Marketing Officer
DULUTH, Ga., Dec. 09, 2019 -- National Vision Holdings, Inc. (NASDAQ: EYE), one of the nation’s largest optical retailers providing quality, affordable eye care and eyewear,.
- Insider Monkey
Hedge Funds Have Never Been This Bullish On National Vision Holdings, Inc. (EYE)
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, smart money investors have to conduct complex analyses, spend many resources and use tools that are not always […]
- Zacks
National Vision (EYE) Up 3.5% Since Last Earnings Report: Can It Continue?
National Vision (EYE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Omnicell to Feature Upgrades in Medication Management at ASHP
Omnicell (OMCL) to showcase innovations in medication management solution portfolio to minimize human errors by care providers.
- Zacks
Myriad Genetics Reports Favorable Study Result on Prequel
Myriad Genetics (MYGN) posts breakthrough results on Prequel Prenatal Screen methodology, proving its superiority over traditional methods.
- Zacks
NuVasive Advances on Global Footprint Despite Pricing Woes
Within NuVasive's (NUVA) U.S. Spinal Hardware business, a strong uptick in case volume and tangible growth in the XLIF and ALIF franchises are major upsides.
- Zacks
Haemonetics (HAE) Launches SafeTrace Tx in North America
Haemonetics (HAE) expands the transfusion management portfolio with SafeTrace Tx, the latest in its transfusion management software product line.
- Zacks
Thermo Fisher Rides on New Product Suite and Global Growth
A series of product launches with better precision medicine initiatives aids Thermo Fisher's (TMO) performance.
- Zacks
EYE or NEOG: Which Is the Better Value Stock Right Now?
EYE vs. NEOG: Which Stock Is the Better Value Option?
- Zacks
ViewRay Allies With Two Majors in MR-Guided Radiation Therapy
ViewRay's (VRAY) collective investments from Elekta and Medtronic are conditioned to the consummation of an equity capital hike of at least $75 million.
- Zacks
RadNet Hits New 52-Week High: What's Driving the Stock?
RadNet (RDNT) is optimistic about maintaining momentum on several positive developments.
- Zacks
Hologic (HOLX) to Showcase Health Solutions Portfolio at RSNA
Hologic (HOLX) to highlight its latest offerings in its breast health portfolio at the ongoing annual RSNA meet.
- Zacks
BioSig Technologies Partners Mayo Clinic to Treat Arrhythmia
BioSig Technologies (BSGM) signs agreement with Mayo Foundation for improving arrhythmia treatment along with covering therapies for autonomic nervous system disease.
- Zacks
Here's Why You Should Invest in ResMed (RMD) Stock Right Now
Investors continue to be optimistic about ResMed (RMD) on its stellar performance.
- Zacks
National Vision Holdings, Inc. (EYE) Shares March Higher, Can It Continue?
As of late, it has definitely been a great time to be an investor in National Vision Holdings, Inc. (EYE).
- Zacks
Medtronic Displays All-Business-Line Growth Despite Cost Woes
Medtronic's (MDT) Diabetes group is expanding internationally on the strong rollout of its MiniMed 670G in untapped markets.
- Zacks
Hologic's LOCalizer RFID Tag in Breast Health Gets CE Mark
Hologic (HOLX) wins the CE Mark for long-term use of LOCalizer RFID tag, providing more flexibility to breast-conserving surgery.
- Zacks
QIAGEN and DiaSorin Get FDA Approval for LIAISON QFT-Plus
QIAGEN (QGEN) and DiaSorin begin the commercial launch of the QFT-Plus test in the United States, following the FDA clearance.
- Zacks
Neogen's (NEOG) Food Safety Test Receives AOAC Clearance
Neogen's (NEOG) Reveal 3-D safety test for checking peanut contamination in food items gets approval from the AOAC.
- Zacks
Bio-Rad's Blood Typing Market Growth Strong on New Products
Bio-Rad's (BIO) new product acceptance in the United States is a positive with the recent 510(k) clearance of the IH-Reader 24.
- Zacks
Amedisys (AMED) to Broaden Hospice Base With Asana Purchase
Asana's acquisition to be the third hospice care buyout of Amedisys (AMED) in 2019.
- Zacks
Medtronic Gets FDA Nod for IN.PACT AV for ESRD Patients
Medtronic (MDT) receives FDA clearance for IN.PACT AV for the treatment of arteriovenous failures in patients undergoing hemodialysis.
